114 related articles for article (PubMed ID: 16973278)
1. Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients.
Jin JK; Kim NH; Lee YJ; Kim YS; Choi EK; Kozlowski PB; Park MH; Kim HS; Min do S
Neurosci Lett; 2006 Oct; 407(3):263-7. PubMed ID: 16973278
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of phospholipase D1 in the brains of scrapie-infected mice.
Jin JK; Kim NH; Min DS; Kim JI; Choi JK; Jeong BH; Choi SI; Choi EK; Carp RI; Kim YS
J Neurochem; 2005 Feb; 92(3):452-61. PubMed ID: 15659216
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease.
Jin JK; Ahn BH; Na YJ; Kim JI; Kim YS; Choi EK; Ko YG; Chung KC; Kozlowski PB; Min do S
Neurobiol Aging; 2007 Jul; 28(7):1015-27. PubMed ID: 16797788
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
5. Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets.
Shi C; Guo K; Yew DT; Yao Z; Forster EL; Wang H; Xu J
Exp Gerontol; 2008 Jun; 43(6):589-94. PubMed ID: 18359596
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
Chen X; Yan SD
IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
[TBL] [Abstract][Full Text] [Related]
7. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
Chen JX; Yan SD
Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
[TBL] [Abstract][Full Text] [Related]
9. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
10. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
11. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo.
Ahn KW; Joo Y; Choi Y; Kim M; Lee SH; Cha SH; Suh YH; Kim HS
J Neurosci Res; 2008 Aug; 86(11):2476-87. PubMed ID: 18438935
[TBL] [Abstract][Full Text] [Related]
12. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H; Shen Y
Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
[TBL] [Abstract][Full Text] [Related]
13. Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation.
Gibson GE; Zhang H; Sheu KF; Bogdanovich N; Lindsay JG; Lannfelt L; Vestling M; Cowburn RF
Ann Neurol; 1998 Oct; 44(4):676-81. PubMed ID: 9778267
[TBL] [Abstract][Full Text] [Related]
14. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains.
Kuhla B; Boeck K; Schmidt A; Ogunlade V; Arendt T; Münch G; Lüth HJ
Neurobiol Aging; 2007 Jan; 28(1):29-41. PubMed ID: 16427160
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor Sp1 dysregulation in Alzheimer's disease.
Citron BA; Dennis JS; Zeitlin RS; Echeverria V
J Neurosci Res; 2008 Aug; 86(11):2499-504. PubMed ID: 18449948
[TBL] [Abstract][Full Text] [Related]
16. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
Atamna H; Frey WH
Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels.
Liron T; Seraya CB; Ish-Shalom M; Souroujon MC; Neumann D
Neuroscience; 2007 Apr; 146(1):152-9. PubMed ID: 17321053
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D1 as a key enzyme for decidualization in human endometrial stromal cells.
Yoon MS; Koo JB; Jeong YG; Kim YS; Lee JH; Yun HJ; Lee KS; Han JS
Biol Reprod; 2007 Feb; 76(2):250-8. PubMed ID: 17065600
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.
Fabbro S; Seeds NW
J Neurochem; 2009 Apr; 109(2):303-15. PubMed ID: 19222708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]